Literature DB >> 21122627

Prevalence of dyslipidemia and its associated factors among Jordanian adults.

Yousef S Khader1, Anwar Batieha, Mohammed El-Khateeb, Mousa Al Omari, Kamel Ajlouni.   

Abstract

BACKGROUND: Dyslipidemia, which has been closely linked to pathophysiology of cardiovascular diseases, is a key independent modifiable risk factor for cardiovascular diseases. Estimation of the prevalence of dyslipidemia ensures proper planning of health actions for both primary and secondary prevention of cardiovascular diseases.
OBJECTIVES: To estimate the prevalence of various types of dyslipidemia and determine their associated factors among adults in north of Jordan.
METHOD: Data were analyzed from a cross-sectional study that included a random sample of 1121 Jordanians aged 25 years and older. High total cholesterol (TC) was defined as TC ≥200 mg/dL and hypertriglyceridemia as serum triglycerides level ≥150 mg/dL. Low high-density lipoprotein cholesterol (HDL-C) was defined as serum HDL-C <40 mg/dL. High low-density lipoprotein cholesterol (LDL-C) was defined as serum LDL-C ≥130 mg/dL.
RESULTS: Of a total of 1121 subjects, 48.8% had high TC level, 40.7% had high LDL-C, 40.1% had low HDL-C, 43.6% had high triglyceride levels, and 75.7% had at least one abnormal lipid level. Age was associated with high triglycerides, high LDL-C, and high TC. Men were more likely than women to have a high triglycerides level and low HDL-C. Compared with people with a body mass index <25, overweight and obese subjects had greater odds of having high triglycerides, high TC, and low HDL-C. Diabetes was associated with increased odds of high triglycerides only.
CONCLUSION: The prevalence dyslipidemia is high in Jordan, which necessitates appropriate the institution of community-based intervention strategies to prevent and manage cardiovascular risk factors.
Copyright © 2010 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21122627     DOI: 10.1016/j.jacl.2009.12.004

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  23 in total

1.  Metabolic syndrome between two ethnic minority groups (Circassians and Chechens) and the original inhabitants of Jordan.

Authors:  Rana Dajani; Yousef S Khader; Nancy Hakooz; Raja Fatahalla; Farouk Quadan
Journal:  Endocrine       Date:  2012-06-28       Impact factor: 3.633

2.  Variables associated with poor health-related quality of life among patients with dyslipidemia in Jordan.

Authors:  Anan S Jarab; Eman A Alefishat; Walid Al-Qerem; Tareq L Mukattash; Lina Abu-Zaytoun
Journal:  Qual Life Res       Date:  2021-01-01       Impact factor: 4.147

3.  Prevalence of food insecurity among women in northern Jordan.

Authors:  Hiba A Bawadi; Reema F Tayyem; Amal N Dwairy; Nemeh Al-Akour
Journal:  J Health Popul Nutr       Date:  2012-03       Impact factor: 2.000

4.  [Prevalence of dyslipemia in Aristide le Dantec biochemistry laboratory in Dakar Senegal].

Authors:  Fatou Cissé; Fatou Diallo Agne; Alassane Diatta; Abdou Salam Mbengue; Arame Ndiaye; Abdourahmane Samba; Souleymane Thiam; Dominique Doupa; Gaston Ndéné Sarr; Niama Diop Sall; Méissa Touré
Journal:  Pan Afr Med J       Date:  2016-10-03

5.  Prevalence of dyslipidemia and its association with other coronary artery disease risk factors among urban population in Southeast of Iran: results of the Kerman coronary artery disease risk factors study (KERCADRS).

Authors:  Hamid Najafipour; Mostafa Shokoohi; Gholamreza Yousefzadeh; Behzad Sarvar Azimzadeh; Gholamreza Moshtaghi Kashanian; Mohamad Mehdi Bagheri; Ali Mirzazadeh
Journal:  J Diabetes Metab Disord       Date:  2016-10-21

6.  Evaluation of cardiovascular risk factors in women referring to health centers in Tabriz, Iran, 2017.

Authors:  Roghayeh Molani Gol; Maryam Rafraf; Mohammad Asghari Jafarabadi
Journal:  Health Promot Perspect       Date:  2018-10-27

7.  Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study.

Authors:  Shashank R Joshi; Ranjit Mohan Anjana; Mohan Deepa; Rajendra Pradeepa; Anil Bhansali; Vinay K Dhandania; Prashant P Joshi; Ranjit Unnikrishnan; Elangovan Nirmal; Radhakrishnan Subashini; Sri Venkata Madhu; Paturi Vishnupriya Rao; Ashok Kumar Das; Tanvir Kaur; Deepak Kumar Shukla; Viswanathan Mohan
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

8.  Lipid profile frequency and the prevalence of dyslipidaemia from biochemical tests at Saint Louis University Hospital in Senegal.

Authors:  Dominique Doupa; Abdou Salam Mbengue; Fatou Agne Diallo; Modou Jobe; Arame Ndiaye; Adama Kane; Alassane Diatta; Meissa Touré
Journal:  Pan Afr Med J       Date:  2014-01-31

9.  High prevalence of dyslipidemia and associated risk factors among rural Chinese adults.

Authors:  Guo-Zhe Sun; Zhao Li; Liang Guo; Ying Zhou; Hong-Mei Yang; Ying-Xian Sun
Journal:  Lipids Health Dis       Date:  2014-12-12       Impact factor: 3.876

10.  Dyslipidemia Prevalence in Iranian Adult Men: The Impact of Population-Based Screening on the Detection of Undiagnosed Patients.

Authors:  Abolfazl Mohammadbeigi; Esamil Moshiri; Narges Mohammadsalehi; Hossein Ansari; Ali Ahmadi
Journal:  World J Mens Health       Date:  2015-12-23       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.